Related Experiment Videos

Dopamine beta-hydroxylase. Inactivation by a suicide substrate

Insights

p-hydroxybenzylcyanide (PHBC) acts as a suicide substrate, inactivating dopamine beta-hydroxylase. The enzyme converts PHBC into p-hydroxymandelonitrile (PHMN), the inactivating species, demonstrating a novel mechanism for enzyme inhibition.

Area of Science:

  • Biochemistry
  • Enzyme kinetics
  • Pharmacology

Background:

  • Dopamine beta-hydroxylase (DBH) is crucial for synthesizing catecholamines.
  • Understanding enzyme inactivation mechanisms is vital for drug development.
  • p-hydroxybenzylcyanide (PHBC) was investigated as a potential enzyme inhibitor.

Purpose of the Study:

  • To elucidate the mechanism by which PHBC inactivates dopamine beta-hydroxylase.
  • To determine if PHBC functions as a suicide substrate.
  • To identify the specific metabolite responsible for enzyme inactivation.

Main Methods:

  • Enzyme kinetics assays to determine inhibition constants and reaction orders.
  • Enzyme activity assays under varying conditions (O2, ascorbate).
  • Product identification and stability studies.

Main Results:

  • PHBC inactivates dopamine beta-hydroxylase via a time-dependent, saturable process.
  • PHBC is converted to p-hydroxymandelonitrile (PHMN), which irreversibly inactivates the enzyme.
  • p-tyramine protects against inactivation, and PHMN is the primary inactivating species.

Conclusions:

  • PHBC meets the criteria for a suicide substrate for dopamine beta-hydroxylase.
  • PHMN is identified as the active inactivating metabolite.
  • This study reveals a novel mechanism of DBH inhibition.

Related Concept Videos